Table 5.

IPDASi-SF results

Publication	Arterburn 2011 [21]	Jibaja-Weiss 2011 [23]	LeBlanc 2015 [24]Montori 2011 [28]	LeBlanc 2015 [24]	Mathers 2012 [27]	Mott 2014 [28]	Mullan 2009 [30]Branda 2013 [22]	Solberg 2010 [31]	Vandemheen 2009 [32]	Weymiller 2007 [33] Mann 2010 [26] Branda 2013 [22]
Production Year	2014 (update)	2006	2007	2012	2008	-	-	2014 (update)	2006	2007
Information
Options available	+	+	+	+	+	+	+	+	+	+
Positive features	+	+	+	+	+	+	+	+	+	+
Negative features	+	+	+	+	+	+	+	+	+	+
Fair comparison	+	+	+	+	+	+	+	+	+	+
Probabilities
Reference class	+	-	+	+	+	+	+	+	+	+
Event rates	+	-	+	-	+	-	-	-	+	+
Compare probabilities	+	-	+	+	+	+	-	+	-	+
Values
Personal importance	+	+	-	-	+	+	-	+	+	-
Development
Patients’ needs	+	+	+	+	+	-	+	+	+	+
Impartial review	+	+	+	+	+	+	+	+	+	+
Tested with patients	-	+	+	+	+	+	+	-	-	+
Disclosure
Information about funding	+	+	+	+	+	+	+	+	+	+
DST evaluation
Knowledge	+	+	+	+	+	-	+	+	+	+
Improved decision quality	+	+	-	+	+	-	-	+	+	+
Evidence
Citations to studies	+	+	+	+	+	-	+	+	+	+
Production date	+	+	+	+	+	-	-	+	+	+
Total	15	13	14	14	16	10	11	14	14	15

+ Met criterion; ? Unclear; - Unmet criterion